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One single-tube PCR assay to detect both CD17 (A>T) and IVS-II nt-654 (C>T)
homozygous mutations of β-thalassemia
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Aim: Several methods can be used to detect gene mutations associated with β-thalassemia, but it is difficult to achieve reliable and
reproducible results. In this study, we introduce a new method, a single-tube multiplex polymerase chain reaction (PCR) assay, to detect
both CD17 (A>T) and IVS-II nt-654 (C>T) homozygous mutations.
Materials and methods: This new method designs specific primers to diagnose homozygous mutations and normal controls.
Results: After PCR amplification, homozygous mutations produce different fragments from normal controls.
Conclusion: This study represents an important step towards the development of a novel protocol to diagnose β-thalassemia and other
diseases that target numerous mutations.
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1. Introduction
β-Thalassemia (β-thal) is a severe disorder of β-globin
gene expression characterized by hypochromic, hemolytic
anemia and inherited as an autosomal disorder (1,2). In
general, each ethnic group appears to carry its own profile
of mutant alleles. Currently, 265 different point mutations
(http://globiin.bx.psu.edu) have been characterized to
be associated with β-thal (3–6), 4 of which can account
for about 87% of the occurrence of β-thal. In descending
frequencies, these 4 mutations are codon CD41/42(CTTT), IVS-II nt-654 (C>T), CD17 (A>T), and TATA box
nt-28 (A>G) (7). In China, β-thal, with carrier frequencies
ranging from 0.02% to 4.8%, affects an estimated 20
million people that are predominantly distributed in
Guangxi, Guangdong, Hainan, and Yunnan provinces (8).
The universality of this disease produces great mental and
economic pressure upon society and the patients’ families,
which no doubt prevents the development of the public
health in southern China (9).
The main clinical diagnostic methods of β-thal
are polymerase chain reaction-reverse dot blot (PCRRDB), real-Time PCR, the polymerase chain reactionamplification refractory mutation system (PCR-ARMS),
* Correspondence: jokaing@163.com
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restriction fragment length polymorphism (RFLP),
antisense oligodeoxynucleotide (ASO), single-strand
conformation polymorphism (SSCP), and Gene Chip
(10–13). It took us about 8 h to complete the procedure
including PCR and RDB. Previously, the PCR method
has been proven to be simple, very sensitive, and specific
for the routine diagnosis of β-thal mutation. However, it
is difficult to achieve reliable and reproducible results in
comparison with a single-tube multiplex PCR assay. In
this study, a single-tube multiplex PCR assay has been
successfully used to diagnose the 2 most widely occurring
β-globin gene mutations in China.
2. Materials and methods
2.1. Patients and samples
In total, 40 unrelated patients (19 females and 21 males,
mean age of 40.5 ± 12.9 years) and 20 control patients
(12 females and 8 males, mean age of 41.3 ± 6.8 years)
were investigated in this study. All patients had no other
diseases. All individuals enrolled gave informed written
consent as approved by the local institutional review
board. The investigated mutations included 20 CD17
(A>T) homozygous mutations and 20 IVS-II-654 (C>T)
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homozygous mutations. Genomic DNA was isolated from
whole blood of participants using the Puregene DNA
Isolation Kit (QIAGEN, Hong Kong).
2.2. Primer designs
Giving the detection of the CD17 (A>T) homozygous
mutation for an example, we carried out a parallel
multiplex PCR reaction by using a pair of primers,
5’-ATTGCTTACATTTGCTTCTG-3’
and
5’-ACTTCATCCACGTTCAGCTT-3’, for the specific
amplification of the CD17A and CD17T alleles, respectively
(128-bp fragments; Table 1). The reverse primer differs only
in the mutated nucleotide at its 3’ end. We inlet a C > G change
(the modified nucleotide is underlined), which will cause
an additional mismatch to increase the allele specificity
of the reaction, shorten the annealing temperature, and
rule out the nonspecific PCR amplification. The specific
mismatch site could provide a relatively large difference
of melting temperature. We also introduced another pair
of primers, 5’-TGATAATTTCTGGGTTATGGT-3’ and
5’-AATATCCCCCAGTTTAGTAG-3’, for the detection
of the IVS-II-654 (C>T) homozygous mutation (Table 1).
GeneTool (GeneBio, Switzerland) software was used to
design the primers.
2.3. PCR reaction
PCR reaction was carried out in a Bio-Rad S1000 PCR
System (Bio-Rad Laboratories, USA) with 1 cycle of
denaturation at 95 °C for 5 min; 5 touch-down cycles of
denaturation at 94 °C for 40 s, annealing for 40 s at 53
°C for the first cycle, and a 1 °C reduction per cycle; 25
cycles of denaturation at 94 °C for 40 s and annealing at 48

°C for 40 s; and a final extension step at 72 °C for 7 min.
The reaction was carried out in a final volume of 50 µL
at the same concentration of 4 primers for CD17 (A>T)
and IVS-II-654 (C>T) homozygous mutations, with a final
concentration of 1 or 2.5 mM magnesium chloride and 100
ng of DNA template, using Taq DNA polymerase (TaKaRa,
China). PCR products were separated by agarose gel
electrophoresis (2.0% agarose gel; Figure 1) and visualized
using Bio-Rad Chemi Doc XRS (Bio-Rad Laboratories).
Fragment size was determined by comparison to a 2-kb
DNA marker (Invitrogen, USA). DNA sequencing of the
β-globin gene was performed using 2 pairs of primers
flanking the 3 exons of β-globin genes, and DNA was
amplified using Taq DNA polymerase (TaKaRa) in the
Bio-Rad S1000 PCR System (Bio-Rad Laboratories). The
primers and product lengths are shown in Table 2. The
PCR product was sequenced using the ABI3700 (ABI,
USA) and visualized using the Chromas program.
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Figure 1. One specific single-tube polymerase chain reaction for
both CD17 (A>T) and IVS-II-654 (C>T) homozygous mutations.
Lane 1 was 2-kb DNA marker; 2 was CD17T-specific PCR; 7 was
IVS-II-654T–specific PCR; 3, 4, 5, and 6 were normal controls.

Table 1. PCR primer sequences, fragment sizes, and gene location.
ID

Primer sequence (5’-3’)

Fragment size (bp)

GenBank No. : nucleotides

No.1
No.2

ATTGCTTACATTTGCTTCTG
ACTTCATCCACGTTCAGCTT

128

NG_000007 : 70538-70557
NG_000007 : 70646-70665

No.3
No.4

TGATAATTTCTGGGTTATGGT
AATATCCCCCAGTTTAGTAG

422

NG_000007 : 71673-71693
NG_000007 : 72075-72094

Table 2. β-Globin primers for PCR and sequencing.
Gene

Primer sequence (5’-3’)

β1 (exon1-2)

Forward: GTACGGCTGTCATCACTTAGACCTCA
Reverse: TGCAGCTTGTCACAGTGCAGCTCACT

β2 (exon3)

Forward: GTGTACACATATTGACCAAA
Reverse: AGCACACAGACCAGCACGTT

Fragment size (bp)

GenBank No. : nucleotides

602

NG_000007 : 70416-70441
NG_000007 : 70992-71017

423

NG_000007 : 71496-71515
NG_000007 : 71899-71918
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3. Results
The electrophoresis results showed that the single-tube
multiplex PCR assay worked well (Figure 2). CD17 (A>T)
and IVS-II-654 (C>T) homozygous mutations could be
detected in a single tube. After amplification, the CD17
(A>T) samples could produce a 128-bp fragment with
the combination of 4 primers. Meanwhile, the IVS-II-654
(C>T) samples could produce a 422-bp fragment with the
combination of 4 primers. However, the normal control
samples produced no fragment using the combination of
4 primers. In a verification test, all samples that had been
detected by DNA sequencing were analyzed by single-tube
PCR assay, and the results showed complete agreement
between the new method and sequencing analysis. To
evaluate the reproducibility of the single-tube PCR assay,
all samples were tested 5 times, and all the mutant and
wild-type blots showed the same depth of color every time.
Heterozygous samples were excluded since this method
was a qualitative analysis and could not discriminate
between heterozygous samples and homozygous samples.
For detecting more homozygous mutations in future
studies, reducing the requirements of multiple reaction
conditions in a single tube, we did not use internal control
in this PCR assay, but negative nontemplate controls were
included in each PCR. PCR products were subjected to
electrophoresis on agarose gels and sequenced.
A

CD17(A>T)

4. Discussion
Although β-thal is a genetic disease that has been well
characterized at the DNA level, mutation detection
in the β-globin gene is still based on time-consuming
methodologies,
requiring
cumbersome
sample
manipulation. Commonly, the occurring mutations of
the β-globin gene are detected by a number of PCR-based
procedures, such as RDB analysis or primer-specific
amplification with a set of probes (10,13). Other methods
based on real-time PCR or microarray technology (11,12)
are incompatible for the routine clinical laboratory because
of their cost and complexity.
In view of the above drawbacks, in this study, we have
explored a different approach based on specific primers.
It is indicated that single-tube multiplex PCR assay could
quickly and simply detect both CD17 (A>T) and IVSII-654 (C>T) homozygous mutations. The frequency of
CD17 (A>T) and IVS-II-654 (C>T) mutations in China is
0.10%–1.59% and 0.57%–0.63%, respectively (14,15).We
found that this method is less laborious, less expensive,
and faster, which makes it more suitable for routine
diagnosis. Therefore, this method can be well extended to
detect other gene mutations.
It should also be noted that the single-tube multiplex
PCR assay has some limitations. For example, we can
only detect 2 homozygous mutations in a single tube; a
heterozygous mutation (a mutation of only 1 allele) and

CD17A

B

IVS-II-654(A>T)

IVS-II-654C

Figure 2. Sequencing results of (A) homozygous CD17 (A>T) mutation and wild type, (B) homozygous IVS-II-654 (C>T)
mutation and wild type.
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compound heterozygous mutations (2 different mutations
in the paternal and maternal alleles) could not be detected
at present. However, we expect that this method will
be perfected with continuous improvement of various
analytical techniques.
In summary, this study represents an important step
toward the development of a novel protocol to diagnose
β-thal and other diseases that target numerous mutations.
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